Validation of Receptor Occupancy Simulation
NCT01660880 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7
Last updated 2019-04-08
Summary
* To estimate dopamine receptor occupancy by aripiprazole using computer simulation
* To measure dopamine receptor occupancy by aripiprazole in patients treated with the antipsychotics
* To validate the simulation result by comparing the receptor occupancy from the simulation with that from the patients
Conditions
- Dopamine Receptor Occupancy
- Medication Satisfaction
- Prolactin Level
- Schizophrenia
Sponsors & Collaborators
-
Seoul National University Hospital
lead OTHER
Principal Investigators
-
Jun Soo Kwon, M.D., Ph.D. · Seoul National University Hospital
Eligibility
- Min Age
- 20 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-12-31
- Primary Completion
- 2013-12-31
- Completion
- 2014-04-30
Countries
- South Korea
Study Locations
More Related Trials
-
A Study of Aripiprazole in the Management of Patients With Schizophrenia in the General Psychiatric Practices
NCT00237939 ·Status: COMPLETED ·Phase: PHASE3
-
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable Schizophrenia
NCT02320032 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Aripiprazole Lauroxil in Subjects With Schizophrenia or Schizoaffective Disorder
NCT02636842 ·Status: COMPLETED ·Phase: PHASE1
-
A Multicenter Study to Evaluate the Effects of Switching to Aripiprazole 12 Weeks on the Sexual Dysfunction From Risperidone or Paliperidone in Patients With Schizophrenia Spectrum Disorders or Bipolar Spectrum Disorders
NCT01742390 ·Status: UNKNOWN ·Phase: PHASE4
-
Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease
NCT00095810 ·Status: COMPLETED ·Phase: PHASE4
-
Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory Schizophrenia
NCT00328367 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacologic Treatment of Acute Episode of Schizophrenia: a Real World Study
NCT03289026 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of the Effects of Aripiprazole and Risperidone on the Pattern of Brain Activation in Schizophrenic Patients
NCT01109147 ·Status: COMPLETED ·Phase: PHASE4
-
Effect on Cognitive Function of a Treatment With Aripiprazole
NCT00329810 ·Status: COMPLETED ·Phase: PHASE4
-
An Open-Label, Multicenter, Rollover, Long-term Study of Aripiprazole Intramuscular Depot in Participants With Schizophrenia
NCT01129882 ·Status: COMPLETED ·Phase: PHASE3
-
Aripiprazole, Abilify Maintena Collaborative Clinical Protocol
NCT02717130 ·Status: TERMINATED ·Phase: NA
-
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
NCT00731549 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices
NCT00292409 ·Status: COMPLETED ·Phase: PHASE3
-
Effect on Metabolic Parameters of Abilify in SPR
NCT00569764 ·Status: UNKNOWN
-
Effect of Switch to Aripiprazole on Health and Smoking Parameters in Patients With Schizophrenia: A Pilot Study
NCT00167817 ·Status: COMPLETED ·Phase: PHASE4
-
Aripiprazole IM Depot for Chinese Patients With Schizophrenia
NCT03287505 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia
NCT03345979 ·Status: COMPLETED ·Phase: PHASE3
-
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
NCT00706654 ·Status: COMPLETED ·Phase: PHASE3
-
Striatal Connectivity and Clinical Outcome in Psychosis
NCT02822092 ·Status: COMPLETED
-
Improving Outcomes in Psychosis Associated With Substance Use Using Aripiprazole
NCT01155544 ·Status: WITHDRAWN ·Phase: PHASE4
-
Efficacy and Safety Study of Aripiprazole to Treat Schizophrenia
NCT00202007 ·Status: COMPLETED ·Phase: PHASE2
-
Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode
NCT04203056 ·Status: TERMINATED ·Phase: PHASE4
-
Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With Schizophrenia
NCT03150771 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type
NCT00036114 ·Status: COMPLETED ·Phase: PHASE3
-
Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia
NCT00283179 ·Status: COMPLETED ·Phase: PHASE3